BTC Capital Management Inc. grew its holdings in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 5.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 91,380 shares of the company’s stock after acquiring an additional 4,604 shares during the period. Procter & Gamble comprises approximately 0.9% of BTC Capital Management Inc.’s portfolio, making the stock its 29th largest position. BTC Capital Management Inc.’s holdings in Procter & Gamble were worth $13,093,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of the stock. Halbert Hargrove Global Advisors LLC acquired a new position in Procter & Gamble during the 3rd quarter worth $25,000. Saranac Partners Ltd acquired a new stake in Procter & Gamble in the 3rd quarter valued at about $30,000. Corundum Trust Company INC purchased a new position in shares of Procter & Gamble in the 3rd quarter valued at about $32,000. Caitlin John LLC purchased a new position in shares of Procter & Gamble in the 3rd quarter valued at about $34,000. Finally, Marquette Asset Management LLC acquired a new position in shares of Procter & Gamble during the third quarter worth about $37,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Procter & Gamble
In other news, insider Moses Victor Javier Aguilar sold 15,169 shares of Procter & Gamble stock in a transaction on Friday, February 13th. The shares were sold at an average price of $162.28, for a total value of $2,461,625.32. Following the transaction, the insider directly owned 44,735 shares of the company’s stock, valued at $7,259,595.80. The trade was a 25.32% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Marc S. Pritchard sold 95,903 shares of the stock in a transaction on Friday, January 23rd. The stock was sold at an average price of $151.15, for a total transaction of $14,495,738.45. Following the sale, the insider owned 182,607 shares of the company’s stock, valued at approximately $27,601,048.05. This represents a 34.43% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 348,618 shares of company stock valued at $55,462,643. 0.20% of the stock is owned by company insiders.
Trending Headlines about Procter & Gamble
- Positive Sentiment: OLAY peptide research — New clinical and mechanistic data presented for OLAY highlight proprietary peptide technology and cell‑adhesion targets that P&G plans to move rapidly into formulations; successful commercialization could bolster pricing power and organic growth for a core beauty brand. OLAY Peptide Research Puts New Spotlight On Procter And Gamble Valuation
- Positive Sentiment: Analysts remain constructive in places — coverage notes that P&G can fare better than peers amid sluggish consumer sentiment, supporting the view of PG as a relatively defensive consumer staples holding. Analysts Constructive on The Procter & Gamble (PG) Amid Sluggish Consumer Sentiment
- Neutral Sentiment: Recent trading strength — PG ticked higher while the broader market fell on 3/30, showing relative strength that may reflect defensive demand; however this was a short‑term move rather than new fundamental news. Procter & Gamble (PG) Ascends While Market Falls: Some Facts to Note
- Neutral Sentiment: Q4 results mixed — Q4 EPS slightly beat estimates (+$0.02) while revenue marginally missed; steady margins and cash flow help the case for the dividend and buybacks, but top‑line softness tempers upside. (Earnings detail from recent company report.)
- Neutral Sentiment: Deutsche Bank trimmed its price target (from $171 to $162) but kept a Hold — this narrows upside but is not a sell signal; investors should weigh this against other analyst views. Deutsche Bank Lowers Price Target on PG
- Neutral Sentiment: Unrelated retailer weakness — a separate report on RH’s weak quarter is unlikely to directly affect PG but signals broader discretionary‑spending challenges in retail. RH (RH) Lags Q4 Earnings and Revenue Estimates
- Negative Sentiment: TD Cowen cut its price target to $142 (from $156) and kept a Hold, citing oil‑linked input cost inflation tied to the Iran war that it believes P&G cannot fully absorb — this is the main near‑term headwind pressuring the stock. Wall Street Downgrades Procter & Gamble Amid Iran War Cost Pressures and More
Analyst Ratings Changes
Several analysts recently weighed in on PG shares. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Procter & Gamble from $171.00 to $162.00 and set a “hold” rating on the stock in a report on Monday. Barclays set a $155.00 price target on shares of Procter & Gamble in a report on Friday, January 16th. Jefferies Financial Group upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and raised their price objective for the company from $156.00 to $179.00 in a report on Tuesday, December 16th. Piper Sandler began coverage on shares of Procter & Gamble in a research report on Wednesday, January 7th. They set a “neutral” rating and a $150.00 price objective for the company. Finally, UBS Group boosted their target price on shares of Procter & Gamble from $161.00 to $170.00 and gave the stock a “buy” rating in a research note on Friday, January 23rd. Twelve investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $167.83.
View Our Latest Stock Report on Procter & Gamble
Procter & Gamble Price Performance
PG stock opened at $144.44 on Wednesday. The business has a 50 day moving average price of $153.88 and a 200 day moving average price of $149.88. The company has a quick ratio of 0.51, a current ratio of 0.72 and a debt-to-equity ratio of 0.49. The stock has a market cap of $335.67 billion, a price-to-earnings ratio of 21.40, a PEG ratio of 4.84 and a beta of 0.37. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $174.80.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Friday, January 23rd. The company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.86 by $0.02. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The company had revenue of $22.21 billion for the quarter, compared to analyst estimates of $22.36 billion. During the same period in the prior year, the firm posted $1.88 earnings per share. The firm’s revenue was up 1.5% on a year-over-year basis. Equities research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd were issued a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend was Friday, January 23rd. Procter & Gamble’s dividend payout ratio is presently 62.52%.
Procter & Gamble Company Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Read More
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
